|
|
||||||||
Department of Microbiology and Immunology, University of Miami Medical School, Miami, FL 33136
| Abstract |
|---|
|
|
|---|
| Introduction |
|---|
|
|
|---|
Although it may be important to limit immune responses in early life, it is almost certainly equally important to allow sufficient responsiveness to achieve protection from disease and death. Given the restrictions to responsiveness described in the paragraph above, how can this be achieved? In this study, we describe a phenomenon that may partially compensate for the limitations in immune cell function in neonates. Following CD3/TCR-dependent or -independent activation, greater proportions of neonatal T cells entered the cell cycle more rapidly than did adult T cells. This rapid cell cycle entry occurred both in vitro and in vivo, during homeostatic proliferation in lymphopenic hosts. Experiments in which exogenous cytokines or anti-cytokine mAb were added indicated that the differences between neonatal and adult early cycling were not dependent on differences in early cytokine production. In addition to T cells, greater proportions of neonatal, compared with adult, B cells also showed more rapid cycling following lineage-specific activation. Thus, populations of lymphocytes present in early life have the capacity to enter the cell cycle more quickly and hence may be able to mobilize a more rapid response from an otherwise completely naive population.
| Materials and Methods |
|---|
|
|
|---|
BALB/c mice, originally obtained from Charles River Laboratories (Wilmington, MA), OVA-specific TCR transgenic DO11.10 mice (The Jackson Laboratory, Bar Harbor, ME), and C57BL/6 mice (The Jackson Laboratory) were bred and housed under barrier conditions in the Division of Veterinary Resources at the University of Miami Medical School. Periodic screening showed the colony to be free of commonly occurring infectious agents. Females from timed matings were monitored closely from days 1921 of gestation, and the date of delivery was recorded. Birth day was called day 0.
RAG2-/- mice were purchased from Taconic (Germantown, NY) and similarly bred and housed under barrier conditions.
Cell preparation
Lymph node preparations.
Pools of tissues from
10 neonatal (day 7) or
2 adult (68 wk old) mice were used for the cell preparations. Mesenteric, inguinal, axillary, brachial, and cervical lymph nodes were collected to prepare total lymph node cell suspensions (11).
Enriched CD4+8- thymocyte preparations.
Thymus cell suspensions were incubated with anti-CD8 microbeads (Miltenyi Biotec, Auburn, CA), and CD8+ cells were depleted on negative-selection columns, following the manufacturers suggested protocol. The resultant population contained <1% CD8+ cells and
50% CD4+8- and 50% CD4-8- cells.
CFSE labeling
CFSE was purchased from Molecular Probes (Eugene, OR). Total lymph node cells were labeled with CFSE according to the manufacturers instructions, with the concentrations of cells and CFSE in the labeling reaction adjusted to 5.0 x 106/ml and 0.5 µM, respectively.
Cell culture conditions
Total lymph node cells (5 x 105) were cultured in 200 µl of medium in 96-well culture dishes in the presence or absence of various activators. Culture medium consisted of RPMI 1640 (Life Technologies, Grand Island, NY) containing 1 mM sodium pyruvate (Life Technologies), 2 mM L-glutamine (Life Technologies), 5 x 10-2 mM 2-ME (Life Technologies), 1% penicillin-streptomycin (Life Technologies), and 10% heat-inactivated (56°C; 30 min) FCS (HyClone, Logan, UT). For cytokine assays, culture supernatants were harvested at 24 h, and
-IFN and IL-4 content were assessed using mouse-specific cytokine ELISA kits (Pierce Endogen, Rockford, IL).
Cell activators
Peripheral T cell activation.
145-2C11 mAb, anti-murine CD3-
(12), ascites fluid was used at a 1/2000 dilution, unless indicated otherwise. In some cases, cultures were supplemented with the indicated concentrations of rIL-2 or rIL-4 (R&D Systems, Minneapolis, MN) or with neutralizing anti-IL-4 mAb (11B11; BD PharMingen, San Diego, CA). PMA (Sigma-Aldrich, St. Louis, MO) was used at 12 nM in combination with ionomycin (Calbiochem, La Jolla, CA) at 0.15 µM for adult cells or 0.30 µM for neonatal cells (13). OVA peptide 323339 (14) was synthesized by the Protein Analysis Core Facility (Department of Biochemistry and Molecular Biology, University of Miami Medical School) and used at a final concentration of 0.1 µg/ml, unless otherwise indicated.
Thymocyte activation. Enriched CD4+8- thymocytes were cultured in 96-well culture dishes precoated with 10 µg/well of purified 145-2C11 mAb (11), in the absence or presence of anti-CD28 mAb (BD PharMingen).
B cell activation. LPS (Sigma-Aldrich) was added to a final concentration of 50 µg/ml. Anti-CD40 mAb was a generous gift of Dr. S. Marshall-Clarke (University of Liverpool, Liverpool, U.K.) and was used at 5 µg/ml together with 50200 U/ml murine rIL-4 (Genzyme, Cambridge, MA).
[3H]Thymidine incorporation
Triplicate cultures of lymph node cells were activated with different concentrations of soluble anti-CD3 mAb (145-2C11), as described in Cell activators. At 3, 24, or 48 h of culture, 1 µCi of [3H]thymidine (Amersham Pharmacia Biotech, Piscataway, NJ) was added per 96-well culture. Cells were incubated at 37°C for an additional 20 h, and the cultures were harvested using a PHD harvester (Cambridge Technology, Watertown, MA).
Ab staining
For Ab staining, anti-CD4, anti-CD8, anti-B220, anti-CD25, and anti-CD69 were purchased from BD PharMingen and used as previously described (15).
Propidium iodide (PI)3 staining
Cells were first stained with fluorescein-conjugated anti-CD4, anti-CD8, or anti-B220 mAb and then processed for PI staining as described previously in detail (16). Briefly, cells were suspended in HBSS containing 50% FCS, fixed by the dropwise addition of ice-cold 70% ethanol, to a final concentration of 50%, and held on ice for at least 1 h. After extensive washing, the cells were suspended in HBSS containing 50 µg/ml PI (Sigma-Aldrich) and 50 µg/ml RNase A (Boehringer Mannheim, Indianapolis, IN) and incubated for 1 h at room temperature. Debris and doublets were eliminated from the analyses using pulse width/area discrimination.
Staining with Hoechst and pyronin Y
Cells (1 x 106) were stained with fluorescein-conjugated anti-CD4 mAb and then fixed and permeabilized in 200 µl of Cytofix/Cytoperm (BD PharMingen) for 45 min at 4°C. Cells were washed once with Perm/Wash (BD PharMingen) and resuspended in 1.0 ml 5 µg/ml Hoechst 33342 (Molecular Probes) in PBS containing 0.1% glucose. The cells were incubated at 37°C for 45 min, and pyronin Y (in PBS, 0.1% glucose) was added to a final concentration of 5 µg/ml. After an additional 45 min at 37°C, samples were analyzed on a BD Biosciences (San Jose, CA) LSR equipped with a 488 nm laser line and an HeCd 325 nm UV laser.
| Results |
|---|
|
|
|---|
We previously observed that freshly isolated neonatal T cells, unlike adult T cells, produced large quantities of IL-4 relatively early (within 48 h) following activation with anti-CD3 mAb (13). For adult T cells, IL-4 production generally begins after
3 days and a number of rounds of proliferation (17, 18, 19). Therefore, we wondered whether the early appearance of IL-4 in neonatal cultures was due to accelerated proliferation by neonatal T cells. To test this idea, total lymph node cells from 7-day-old neonatal or adult BALB/c mice were CFSE labeled and stimulated with soluble anti-CD3 mAb. Parallel cultures were prepared in the presence of medium only (unactivated). Twenty-four and 42 h after the initiation of culture, the cells were stained with anti-CD4 or anti-CD8 mAb and analyzed on the flow cytometer (Fig. 1). At 24 h of activation, there was no obvious division by either neonatal or adult cells. By 42 h of activation, both cell types showed clear division peaks. As has been recently reported for Ag-driven stimulation (20), adult CD4+ cells showed more limited proliferation than adult CD8+ cells. This relative phenomenon was also seen for neonatal CD4+ and CD8+ cells. However, among both the CD4+ and CD8+ populations, neonatal cells had clearly undergone more extensive division than the corresponding adult cells. This more rapid division did not require neonatal APC, because similar results were obtained using purified neonatal or adult CD4+ cells and adult APC (data not shown).
|
|
In the CFSE experiments described in the previous section, division peaks were not detectable among either neonatal or adult cultures until
40 h. The cell population present at this time is the cumulative product of the ongoing processes of cell survival, cell proliferation, and cell death. For example, there may be relatively more death among undivided cells within the neonatal population. If so, the proportion of cells in the divided CFSE peaks would be increased proportionally, even if the amount of division was similar in the neonatal and adult cultures. Thus, to minimize the effects of longer term culturing, neonatal and adult cells were analyzed earlier, using PI staining. This method allowed us to monitor two things: 1) the percentage of cells in the different phases of the cell cycle and 2) the presence of apoptotic or sub-G0 cells. Neonatal or adult BALB/c lymph node cells were activated with soluble anti-CD3, and 21 h later, the cells were stained with anti-CD4 mAb, fixed and permeabilized, and stained with PI. Among freshly isolated cells, a small but consistently greater (
2-fold) percentage of neonatal CD4+ cells were in the S plus G2/M stages of the cell cycle, compared with adult cells (Fig. 3, left panel). At 21 h of activation, nearly 50% of neonatal CD4+ cells had entered the cell cycle, compared with
20% of adult CD4+ cells (Fig. 3, right panel). This cell cycle entry was clearly dependent on activation, because similarly cultured but unactivated cells showed low levels of cycling (Fig. 3, middle panel). These experiments also demonstrated similar modest proportions (<10%) of apoptotic (sub-G0) cells among the activated neonatal or adult CD4+ populations at this early culture time, and although the proportions increased later, neonatal and adult CD4+ cells also showed similar percentages of apoptotic cells at 48 h (data not shown) (16). Similar results were obtained when the CD8+ populations were compared, with 4768% of activated neonatal CD8+ cells in cycle compared with 1216% of adult CD8+ cells in S plus G2/M at 21 h of culture (data not shown). These experiments argue strongly that a greater proportion of activated neonatal, compared with adult, T cells enter the cell cycle early.
|
|
5-fold) [3H]thymidine between 3 and 23 h of culture. Between 24 and 44 h of culture, [3H]thymidine uptake by neonatal T cells was approximately twice that of adult T cells. However, by 48 h of culture, adult T cells showed greater [3H]thymidine incorporation. Strikingly, while the radioactivity incorporated by adult T cells was still
100-fold higher than the levels seen in the absence of activation, activated neonatal T cells incorporated
2-fold as much [3H]thymidine as the corresponding unactivated cultures. Together, these data indicate that the faster cycle entry of neonatal T cell populations is followed by their earlier cessation of proliferation.
|
70% of neonatal CD4+ cells showed CD69 expression, as opposed to
50% of adult CD4+ cells (Fig. 6A, top panel). CD8+ cells showed similar relative patterns of CD69 expression (Fig. 6B, top panel). Although somewhat more delayed, greater proportions of neonatal CD4+ and CD8+ cells also showed rapid up-regulation of CD25 expression (Fig. 6, A and B, bottom panels). The rapid up-regulation of these markers was also observed following anti-CD3 stimulation of TCR transgenic DO11.10 neonatal vs adult CD4+ cells (data not shown). These data, together with those obtained with the PI experiments, clearly demonstrate that proportionally more neonatal T cells enter the cell cycle rapidly, compared with adult cells.
|
Newborn mice contain greatly reduced (50- to 100-fold) numbers of peripheral lymphocytes (2). As a result, neonates can be considered lymphopenic relative to adults. T cells isolated from the secondary lymphoid organs of neonates may be primed by peripheral homeostatic signals to undergo rapid cycle entry. Alternatively, the rapid cycling of peripheral T cells in the neonate may be due to their derivation from the neonatal vs the adult thymus. To distinguish between these possibilities, we compared cycling among neonatal vs adult thymocytes. To exclude the major population of immature thymocytes (CD4+8+ double-positive cells) from the analyses, thymocytes from day 1, day 3, and adult animals were enriched for CD4+8- cells (see Materials and Methods). The enriched populations were activated for 24 h with plastic-immobilized anti-CD3 mAb with or without anti-CD28 mAb; control unactivated cultures were plated in medium only in non-mAb-coated wells. The cells were then stained with anti-CD4 mAb, fixed, permeabilized, and stained with PI (Table I). The proportions of apoptotic CD4+8- cells was higher, especially among unactivated cells, than generally observed for peripheral CD4+8- cells (see, for example, Fig. 3). However, in common with peripheral T cells, neonatal CD4+8- thymocytes showed somewhat more (
3-fold) spontaneous proliferation, compared with adult thymocytes, in the absence of activation. Moreover, when activated with anti-CD3 or with anti-CD3 plus anti-CD28, greater proportions of neonatal, compared with adult, CD4+8- thymocytes entered the cycle (percentage of S plus G2/M). Therefore, the rapid cell cycle entry of peripheral T cells in the neonate appears to be inherited from their immediate precursors in the thymus.
|
|
When neonatal lymph node cells are activated with anti-CD3, i.e., the mode of activation used for most of the cycling experiments, we found that they produced high levels of both Th1 and Th2 cytokines as early as 24 h of activation (Fig. 7). This contrasts with adult total lymph node cell cultures that contained markedly less of the Th1 cytokine
-IFN and no detectable IL-4 (Th2 cytokine) at this early time point. Thus, one possible explanation for the faster cycling kinetics of neonatal T cells is that the high levels of cytokine present early act to drive cell cycle entry. This possibility was tested in two ways. First, adult cells were activated in the presence of exogenous IL-2. The prediction in this study is that if adults are cycling more slowly simply because of limiting amounts of early cytokine, the exogenous IL-2 should increase the speed of cycle entry to resemble neonatal T cell cycling. However, over a broad range of rIL-2 concentrations, there was no change in the percentage of adult CD4+ cells entering the cycle (Table III). Similar negative results were obtained in the presence of exogenous rIL-4 (data not shown). In the second approach, neonatal cells were activated in the presence of neutralizing anti-IL-4 mAb. The rationale here is that early cycle entry by neonatal T cells may be promoted by their high IL-4 production, something completely lacking in the early adult cultures. In this case, elimination of the IL-4 signal should slow down cycle entry to resemble adult T cell cycling. Again, however, the presence of anti-IL-4 in the cultures had no effect on the proportions of cycling neonatal CD4+ cells (Table III).
|
|
1.5-fold) over adult CD4+ cells in the percentage of cells in G1. These findings are consistent with the PI results presented in Figure 3, indicating that
1.52 times as many CD4+ cells in neonates, compared with adults, appear to be spontaneously cycling. Nonetheless, the percentage in cycle is low, and it seems unlikely that spontaneous cycling contributes substantially to the large proportion of neonatal CD4+ cells in the S plus G2/M stages of the cell cycle after only 24 h of activation (see Fig. 3).
|
The rapid responses of neonatal T cells to activation signals may be a quality unique to T lineage cells. Alternatively, rapid cycle entry may be a feature common to all lymphoid cells of this developmental age. To distinguish between these possibilities, lymph node cells from neonatal or adult BALB/c mice were stimulated with LPS or with anti-CD40 mAb plus rIL-4 for 24 h. The cells were then stained with anti-B220 mAb, to detect B cells, fixed and permeabilized, and stained with PI. Unlike the T cell populations, freshly isolated and unactivated cultured B cells from both neonates and adults showed a considerable percentage (1020%) of cells in S plus G2/M (Fig. 9, first and second panels from the left). Following 24 of activation with either agent, there was essentially no increase in cycling among adult B cells (Fig. 9, third and fourth panels from the left). In contrast, the percentage of cycling cells in the neonatal B cell population increased at least 2-fold in response to either LPS or anti-CD40 plus rIL-4 stimulation. Similar results were obtained when cells were stimulated with anti-µ mAb (data not shown). Thus, both the B and T cell populations present in early life respond to lineage-specific activation with rapid cell cycle entry.
|
| Discussion |
|---|
|
|
|---|

activation, 2) it occurs in vivo in response to the peptides and/or signals stimulating homeostatic proliferation (reviewed in Refs. 24 and 25), and 3) it is seen in several strains of mice. At least in part, early cell cycle entry may compensate for the lack of immunological memory in neonates, allowing the rapid mobilization of immune effector mechanisms.
The major finding that led to these experiments was that neonatal T cells, unlike adult T cells, make high levels of IL-4 within 48 h of initial activation (13). For adult T cells, Reiner and colleagues (17) made the original observation that IL-4 production occurs at increased frequencies in cells that have undergone at least three cell divisions. We reasoned that neonatal T cells may make high levels of IL-4 early because they divide more rapidly than adult cells. While proportionally more neonatal than adult T cells entered the cell cycle early, no cell division was detected before
36 h of activation (data not shown; see Figs. 1 and 2). In these experiments, we found that large quantities of IL-4 were secreted by neonatal T cells within 24 h of activation (Fig. 7). Thus, neonatal T cells produce high levels of IL-4 before undergoing a single round of cell division. In this regard, neonatal T cells resemble the relatively small proportion of adult cells that can acquire IL-4-secreting potential in the absence of proliferation (26, 27). However, it is important to point out that
37 h of culture time was required before IL-4 production by undivided adult cells was apparent. Thus, whether the cells proliferate or not, some extended time period may be required to remodel the IL-4 locus (17, 28, 29, 30, 31) to allow efficient gene expression. Because neonatal T cells produce IL-4 so rapidly, in a division-independent fashion, it is tempting to speculate that the IL-4 locus is relatively more accessible, e.g., less methylated, in neonates compared with adults. Experiments to test this intriguing possibility are currently underway.
It is generally believed that most fetal, and possibly neonatal, cells proliferate faster than adult cells. However, direct comparisons of cell cycle entry by fetal/neonatal and adult cells are generally lacking. What is clear is that fetal/neonatal cells appear to cycle spontaneously at a higher rate than their adult counterparts. For example, a higher percentage of freshly isolated fetal CD34+ hemopoietic stem cells appear to be in cycle compared with the adult CD34+ population (32, 33). This spontaneous proliferation is not limited to hemopoietic cells. In first-passage cultures, a greater proportion of newborn than adult lung fibroblasts spontaneously enter the S phase of the cell cycle at any time point (34). Smooth muscle cells from neonatal rats, unlike those from adult rats, appear to be competent to proliferate in the absence of exogenous mitogens (35). Among T cell populations, cord blood cells, but not naive adult cells, proliferate in response to IL-7, in the absence of stimulation through the TCR (36, 37). Indeed, in our system, although spontaneous proliferation is not high, there is a reproducibly greater (
2-fold) percentage of freshly isolated neonatal lymph node T cells that appear to be spontaneously in cycle (see Fig. 3, left panel). In addition, a recent report (38) describes significantly greater spontaneous proliferation of neonatal splenic T cells in situ. However, the observations reported in this study are unique in that rapid early entry into the cell cycle is observed following lineage-specific activation of fully differentiated cells. The demonstration that greater proportions of neonatal B cells as well as T cells enter the cycle faster than their adult counterparts indicates that this phenomenon is common to all lymphocytes of this developmental stage. It will be interesting to determine whether other neonatal blood cells, like macrophages and dendritic cells, also share this property.
What are the characteristics of the neonatal lymphocyte population that lead to rapid early cell cycle progression? For T cells, one possibility we entertained was that a greater proportion of neonatal T cells were already in G1 and, thus, entered the S phase of the cycle faster. However, low proportions of both freshly isolated neonatal and adult T cells were found to be in G1 (see Fig. 8). Because neonatal T cells made high levels of cytokine more rapidly than adult T cells, we then postulated that these high early levels of cytokine drove proportionally more neonatal T cells into cycle early. This also did not appear to be the case because 1) adding saturating amounts of exogenous cytokine did not result in faster cell cycle progression by adult T cells and 2) neutralizing anti-IL-4 mAb did not slow down neonatal cell cycle progression (see Table III). Yet another possibility may be found in the relative compositions of neonatal and adult populations. For example, Turka and colleagues (39) have shown that up to 40% of adult T cells fail to progress through the cell cycle, despite showing evidence of an activated state. Due to developmental immaturity, neonatal lymphocytes may lack this population, resulting in a greater proportion of cells responding to activation with early proliferation. Thus, it will be important to measure the absolute number of precursors among the neonatal and adult populations that respond to activation with proliferation (39).
The activation of T cells results in signaling cascades that ultimately lead to cellular proliferation and the acquisition of effector function. Lineage-specific molecular signals are activated, often by phosphorylation, and these signals, in turn, interface with cell cycle machinery common to all cells. The more rapid cycling of neonatal T cells might result from the dysregulation of one or more of these signals. For example, the initial entry of all cells into cycle is controlled by a combination of the up-regulation of positive signals and the down-regulation of negative signals. p27kip is expressed in resting cells of all types and must be degraded to allow cycle entry (reviewed in Refs. 40 and 41). It is conceivable that resting neonatal T cells underexpress p27kip or that p27kip is expressed at normal levels but degraded more rapidly upon activation. T lineage-specific signals may also be affected in neonates. For example, phospholipase C (PLC)-
1 is a central signaling molecule in T cells. Phosphorylation of PLC-
1 on multiple tyrosine residues is required for its activation (reviewed in Ref. 42). It is conceivable that these phosphorylation events occur more rapidly or efficiently in neonatal T cells or even that PLC-
1 may be partially tyrosine phosphorylated in resting neonatal T cells. Clearly, there are numerous candidate signals in the regulation of the relative cell cycle entry of neonatal and adult T cells. We are currently beginning experiments to distinguish among the many possibilities.
| Acknowledgments |
|---|
| Footnotes |
|---|
2 Address correspondence and reprint requests to Dr. Becky Adkins, Department of Microbiology and Immunology, R-138, 1600 NW 10th Avenue, Rosenstiel Medical Science Building Room 3152A, University of Miami Medical School, Miami, FL 33136. E-mail address: radkins{at}med.miami.edu ![]()
3 Abbreviations used in this paper: PI, propidium iodide; PLC, phospholipase C. ![]()
Received for publication September 10, 2002. Accepted for publication March 3, 2003.
| References |
|---|
|
|
|---|
or IL-4. J. Immunol. 166:112.
loci accompany Th1/Th2 differentiation. J. Immunol. 169:647.This article has been cited by other articles:
![]() |
S. J. Opiela, T. Koru-Sengul, and B. Adkins Murine neonatal recent thymic emigrants are phenotypically and functionally distinct from adult recent thymic emigrants Blood, May 28, 2009; 113(22): 5635 - 5643. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Jupelli, M. N. Guentzel, P. A. Meier, G. Zhong, A. K. Murthy, and B. P. Arulanandam Endogenous IFN-{gamma} Production Is Induced and Required for Protective Immunity against Pulmonary Chlamydial Infection in Neonatal Mice J. Immunol., March 15, 2008; 180(6): 4148 - 4155. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Rose, M. Lichtenheld, M. R. Foote, and B. Adkins Murine Neonatal CD4+ Cells Are Poised for Rapid Th2 Effector-Like Function J. Immunol., March 1, 2007; 178(5): 2667 - 2678. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Maurer, S. L. Kostka, F. Siebenhaar, K. Moelle, M. Metz, J. Knop, and E. von Stebut Skin mast cells control T cell-dependent host defense in Leishmania major infections FASEB J, December 1, 2006; 20(14): 2460 - 2467. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. VanCott, A. E. Prada, M. M. McNeal, S. C. Stone, M. Basu, B. Huffer Jr., K. L. Smiley, M. Shao, J. A. Bean, J. D. Clements, et al. Mice Develop Effective but Delayed Protective Immune Responses When Immunized as Neonates either Intranasally with Nonliving VP6/LT(R192G) or Orally with Live Rhesus Rotavirus Vaccine Candidates. J. Virol., May 1, 2006; 80(10): 4949 - 4961. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Woelbing, S. L. Kostka, K. Moelle, Y. Belkaid, C. Sunderkoetter, S. Verbeek, A. Waisman, A. P. Nigg, J. Knop, M. C. Udey, et al. Uptake of Leishmania major by dendritic cells is mediated by Fc{gamma} receptors and facilitates acquisition of protective immunity J. Exp. Med., January 23, 2006; 203(1): 177 - 188. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Franchini, H. Hefti, S. Vollstedt, B. Glanzmann, M. Riesen, M. Ackermann, P. Chaplin, K. Shortman, and M. Suter Dendritic Cells from Mice Neonatally Vaccinated with Modified Vaccinia Virus Ankara Transfer Resistance against Herpes Simplex Virus Type I to Naive One-Week-Old Mice J. Immunol., May 15, 2004; 172(10): 6304 - 6312. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Xing, E. M. Conway, C. Kang, and A. Winoto Essential Role of Survivin, an Inhibitor of Apoptosis Protein, in T Cell Development, Maturation, and Homeostasis J. Exp. Med., January 5, 2004; 199(1): 69 - 80. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Adkins Peripheral CD4+ Lymphocytes Derived from Fetal versus Adult Thymic Precursors Differ Phenotypically and Functionally J. Immunol., November 15, 2003; 171(10): 5157 - 5164. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |